Emergent BioSolutions (EBS) Current Assets (2010 - 2026)
Emergent BioSolutions (EBS) posted Current Assets of $666.0 million for Q2 2026, up 4.45% on a QoQ basis from $637.6 million in Q1 2026, and down 7.44% year-over-year from $719.5 million in Q2 2025.
Powered by 
Analysis
Emergent BioSolutions (EBS) Current Assets (2010 - 2026) Analysis & Trends
Emergent BioSolutions has reported Current Assets for 17 years, with the latest figure at $666.0 million in Q2 2026.
- On a quarterly basis, Current Assets fell 7.44% year-over-year to $666.0 million in Q2 2026; TTM through Jun 2026 was $666.0 million, a 7.44% decrease from a year earlier, with the FY2025 full-year figure at $662.5 million, up 10.66% from the prior year.
- Current Assets was $666.0 million for Q2 2026 at Emergent BioSolutions, up from $637.6 million in the prior quarter.
- The five-year high for Current Assets was $1.2 billion in Q1 2023, with the low at $598.7 million in Q4 2024.
- Average Current Assets over 5 years is $814.9 million, with a median of $713.2 million recorded in 2025.
- The sharpest annual moves came in 2024 and 2025: Current Assets tumbled 44.13% in 2024, then increased 18.97% in 2025.
- Over 5 years, Current Assets stood at $1.2 billion in 2022, then plunged by 43.86% to $679.5 million in 2023, then decreased by 11.89% to $598.7 million in 2024, then climbed by 10.66% to $662.5 million in 2025, then advanced by 0.53% to $666.0 million in 2026.
- The last three Current Assets figures came in at $666.0 million (Q2 2026), $637.6 million (Q1 2026), and $662.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.47 Bn | 628.71 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 467.46 Bn | 460.93 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 369.31 Bn | 362.22 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 269.03 Bn | 261.74 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Pfizer | 158.11 Bn | 146.71 Bn | 10.94 Bn | 41.36 Bn |
| 6 | Bristol Myers Squibb | 127.96 Bn | 116.89 Bn | 9.25 Bn | 28.58 Bn |
| 7 | Sanofi | 51.83 Bn | 44.86 Bn | 10.79 Bn | 36.64 Bn |
| 8 | BeOne Medicines | 41.33 Bn | 36.23 Bn | 1.53 Bn | 7.22 Bn |
| 9 | Revolution Medicines | 41.30 Bn | 41.30 Bn | - | 4.03 Bn |
| 10 | Emergent BioSolutions | 335.50 Mn | 194.60 Mn | 137.20 Mn | 666.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 666.00 Mn |
| Mar 31, 2026 | 637.60 Mn |
| Dec 31, 2025 | 662.50 Mn |
| Sep 30, 2025 | 786.90 Mn |
| Jun 30, 2025 | 719.50 Mn |
| Mar 31, 2025 | 706.80 Mn |
| Dec 31, 2024 | 598.70 Mn |
| Sep 30, 2024 | 661.40 Mn |
| Jun 30, 2024 | 654.50 Mn |
| Mar 31, 2024 | 682.40 Mn |
| Dec 31, 2023 | 679.50 Mn |
| Sep 30, 2023 | 720.80 Mn |
| Jun 30, 2023 | 777.70 Mn |
| Mar 31, 2023 | 1.22 Bn |
| Dec 31, 2022 | 1.21 Bn |
| Sep 30, 2022 | 1.10 Bn |
| Jun 30, 2022 | 1.08 Bn |
| Mar 31, 2022 | 1.10 Bn |
| Dec 31, 2021 | 1.27 Bn |
| Sep 30, 2021 | 1.11 Bn |
API Access
Emergent BioSolutions Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();